Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
47
SMMNY Quote, Financials, Valuation and Earnings
Last price:
$26.19
Seasonality move
:
-2.66%
Day range:
$26.00 - $26.20
52-week range:
$23.28 - $30.19
Dividend yield:
3.83%
P/E ratio:
24.77x
P/S ratio:
2.28x
P/B ratio:
2.77x
Volume:
14.8K
Avg. volume:
136.7K
1-year change:
-3.96%
Market cap:
$58.7B
Revenue:
$25.8B
EPS (TTM):
$1.06
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Siemens Healthineers AG has -- downside to fair value with a price target of -- per share.
SMMNY vs. S&P 500
-
Over the past 5 trading days, Siemens Healthineers AG has underperformed the S&P 500 by -0.95% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Siemens Healthineers AG does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Siemens Healthineers AG has grown year-over-year revenues for 10 quarters straight. In the most recent quarter Siemens Healthineers AG reported revenues of $7.4B.
Earnings Growth
-
Siemens Healthineers AG has grown year-over-year earnings for 8 quarters straight. In the most recent quarter Siemens Healthineers AG reported earnings per share of $0.31.
Enterprise value:
73.9B
EV / Invested capital:
1.90x
Price / LTM sales:
2.28x
EV / EBIT:
19.41x
EV / Revenue:
2.86x
PEG ratio (5yr expected):
1.95x
EV / Free cash flow:
29.36x
Price / Operating cash flow:
23.39x
Enterprise value / EBITDA:
14.10x
Gross Profit (TTM):
$10B
Return On Assets:
4.68%
Net Income Margin (TTM):
9.29%
Return On Equity:
11.65%
Return On Invested Capital:
6.23%
Operating Margin:
14.84%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $23.2B | $24.3B | $25.9B | $7B | $7.4B | |
| Gross Profit | $8.2B | $9.2B | $10B | $2.6B | $2.8B | |
| Operating Income | $2.6B | $3.7B | $3.8B | $1.4B | $1.1B | |
| EBITDA | $4.3B | $5B | $5.2B | $1.7B | $1.5B | |
| Diluted EPS | $0.72 | $0.94 | $1.06 | $0.30 | $0.31 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $12.5B | $13.1B | $15B | $16.1B | $16.6B | |
| Total Assets | $48.6B | $48.1B | $49.4B | $51.4B | $52.1B | |
| Current Liabilities | $11.7B | $11.8B | $14.2B | $12.9B | $14.9B | |
| Total Liabilities | $30B | $28.6B | $30.2B | $31B | $30.9B | |
| Total Equity | $18.6B | $19.4B | $19.2B | $20.4B | $21.3B | |
| Total Debt | $14.3B | $13.7B | $13.2B | $15.2B | $13.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.9B | $2.7B | $3.4B | $1.3B | $1.1B | |
| Cash From Investing | -$1.1B | -$721.3M | -$1B | -$230.1M | -$198.3M | |
| Cash From Financing | -$408.3M | -$1.4B | -$2.9B | -$389.8M | -$1.1B | |
| Free Cash Flow | $1B | $1.9B | $2.5B | $1.1B | $804.3M | |
SMMNY
Sector
Market Cap
$58.7B
$28.1M
Price % of 52-Week High
86.68%
51.39%
Dividend Yield
3.83%
0%
Shareholder Yield
4.4%
-1.49%
1-Year Price Total Return
-3.96%
-17.13%
Beta (5-Year)
1.122
0.518
Dividend yield:
3.83%
Annualized payout:
$0.50
Payout ratio:
-47.9%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$26.07
200-day SMA
Sell
Level
$26.80
Bollinger Bands (100)
Sell
Level
25.42 - 28.12
Chaikin Money Flow
Buy
Level
35.6K
20-day SMA
Buy
Level
$25.44
Relative Strength Index (RSI14)
Buy
Level
59.51
ADX Line
Sell
Level
18.02
Williams %R
Sell
Level
-15.6256
50-day SMA
Buy
Level
$26.07
MACD (12, 26)
Buy
Level
6.88
25-day Aroon Oscillator
Buy
Level
84
On Balance Volume
Neutral
Level
29.3K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.0562)
Sell
CA Score
(Annual)
Level (-0.3945)
Buy
Beneish M-Score
(Annual)
Level (-2.5106)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.8154)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Siemens Healthineers AG is a holding company that provides healthcare equipment, solutions, and services globally. It operates through the following business segments: Imaging, Diagnotics, Varian and Advanced Therapies. The Imaging segment provides imaging products, services, and solutions as well as digital offerings. The Diagnostics segment provides a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Varian segment provides innovative, multi-modality cancer care technologies based on integrated, advanced imaging, along with solutions and services to oncology departments in hospitals and clinics globally. The Advanced Therapies segment consist of integrated products, services and solutions across multiple clinical fields used in the treatment of diseases. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Forchheim, Germany.
Stock Forecast FAQ
In the current month, SMMNY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SMMNY average analyst price target in the past 3 months is --.
-
Where Will Siemens Healthineers AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Siemens Healthineers AG share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Siemens Healthineers AG?
Analysts are divided on their view about Siemens Healthineers AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Siemens Healthineers AG is a Sell and believe this share price will rise from its current level to --.
-
What Is Siemens Healthineers AG's Price Target?
The price target for Siemens Healthineers AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SMMNY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Siemens Healthineers AG is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SMMNY?
You can purchase shares of Siemens Healthineers AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Siemens Healthineers AG shares.
-
What Is The Siemens Healthineers AG Share Price Today?
Siemens Healthineers AG was last trading at $26.19 per share. This represents the most recent stock quote for Siemens Healthineers AG. Yesterday, Siemens Healthineers AG closed at $26.17 per share.
-
How To Buy Siemens Healthineers AG Stock Online?
In order to purchase Siemens Healthineers AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get SMMNY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SMMNY
Sector
P/E ratio
24.77x
23.89x
PEG ratio
1.95x
-0.01x
P/B ratio
2.77x
1.81x
Price / LTM sales
2.28x
1.59x
Growth Metrics
SMMNY
Sector
Revenue growth
6.26%
4.62%
Earnings growth
2.06%
11.06%
Revenue (5-year growth)
9.78%
6.5%
Earnings forecast
--
-$0.21
Profitability
SMMNY
Sector
Profitability FY 2025
$10B
$3.6M
Return on invested capital
6.23%
-31.84%
Return on assets
4.68%
-27.96%
Return on equity
11.65%
-37.63%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Feb
4
Balance Sheet
SMMNY
Sector
Total cash
$2.6B
$26.4M
Short term investments
$102.8M
$25.7M
Total assets
$52.1B
$76.9M
Long term debt
$13.5B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
